Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 310628, 16 pages
http://dx.doi.org/10.1155/2013/310628
Review Article

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis

1West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
2Department of Rheumatology and Immunology, The First People’s Hospital of Yibin, Yibin, Sichuan 644000, China
3Department of Otolaryngology, The First People’s Hospital of Yibin, Yibin, Sichuan 644000, China
4The Chinese Cochrane Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
5Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China

Received 1 May 2013; Revised 15 September 2013; Accepted 18 September 2013

Academic Editor: Xuan Zhang

Copyright © 2013 Jiangtao Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jiangtao Li, Hejuan Mao, Yan Liang, et al., “Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis,” Clinical and Developmental Immunology, vol. 2013, Article ID 310628, 16 pages, 2013. https://doi.org/10.1155/2013/310628.